β-synuclein gene alterations in dementia with Lewy bodies

Neurology

Volumn 63, Issue 5, 2004, Pages 805-811

  Ohtake, H ^a   Limprasert, P ^b,k   Fan, Y ^b   Onodera, O ^a   Kakita, A ^a   Takahashi, H ^a   Bonner, L T ^b,c   Tsuang, D W ^b,c   Murray, I V J ^f   Lee, V M Y ^f   Trojanowski, J Q ^f   Ishikawa, A ^g   Idezuka, J ^h   Murata, M ⁱ   Toda, T ^j   Bird, T D ^b,d   Leverenz, J B ^b,c,d,e   Tsuji, S ⁱ   La Spada, Albert R ^b  

^a NIIGATA UNIVERSITY   (Japan)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c Education   (United States)

^d Education and Clinical Center   (United States)

^e Department of Veterans Affair   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g National Hospital Organization   (Japan)

^h Ojiya General Hospital   (Japan)

ⁱ UNIVERSITY OF TOKYO   (Japan)

^j OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^k PRINCE OF SONGKLA UNIVERSITY   (Thailand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; BETA SYNUCLEIN; HISTIDINE; METHIONINE; PROLINE; VALINE;

AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DEMENTIA; GENE MUTATION; GENETIC POLYMORPHISM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; NEUROTOXICITY; PARKINSON DISEASE; PENETRANCE; PRIORITY JOURNAL; PROTEIN AGGREGATION;

EID: 4644359042     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000139870.14385.3C     Document Type: Article

References (30)

1. Lang AE, Lozano AM. Parkinson's disease: first of two parts. N Engl J Med 1998;339:1044-1053.
2. Goedert M. Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2001;2:492-501.
3. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
4. Hansen LA, Samuel W. Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies. Neurology 1997;48:126-132.
5. Okazaki H, Lipkin LE, Aronson SM. Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol 1961;20:237-244.
6. Kosaka K. Diffuse Lewy body disease. Neuropathology 2000;20(suppl): S73-S78.
7. Riess O, Jakes R, Kruger R. Genetic dissection of familial Parkinson's disease. Mol Med Today 1998;4:438-444.
8. Chung KK, Dawson VL, Dawson TM. New insights into Parkinson's disease. J Neurol 2003;250(suppl 3):III15-24.
9. Lavedan C, Buchholtz S, Nussbaum RL, Albin RL, Polymeropoulos MH. A mutation in the human neurofilament M gene in Parkinson's disease that suggests a role for the cytoskeleton in neuronal degeneration. Neurosci Lett 2002;322:57-61.
10. Marx FP, Holzmann C, Strauss KM, et al. Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease. Hum Mol Genet 2003;12:1223-1231.
11. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
12. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A 1998;95:6469-6473.
13. Lavedan C. The synuclein family. Genome Res 1998;8:871-880.
14. Galvin JE, Lee VM, Trojanowski JQ. Synucleinopathies: clinical and pathological implications. Arch Neurol 2001;58:186-190.
15. Kahle PJ, Neumann M, Ozmen L, et al. Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain. J Neurosci 2000;20:6365-6373.
16. Mori F, Nishie M, Yoshimoto M, Takahashi H, Wakabayashi K. Reciprocal accumulation of beta-synuclein in alpha-synuclein lesions in multiple system atrophy. Neuroreport 2003;14:1783-1786.
17. Rockenstein E, Hansen LA, Mallory M, Trojanowski JQ, Galasko D, Masliah E. Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease. Brain Res 2001;914:48-56.
18. Uversky VN, Li J, Souillac P, et al. Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. J Biol Chem 2002;277:11970-11978.
19. Hashimoto M, Rockenstein E, Mante M, Mallory M, Masliah E. Beta-synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. Neuron 2001;32:213-223.
20. Giasson BI, Jakes R, Goedert M, et al. A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease. J Neurosci Res 2000;59:528-533.
21. Lincoln S, Crook R, Chartier-Harlin MC, et al. No pathogenic mutations in the beta-synuclein gene in Parkinson's disease. Neurosci Lett 1999;269:107-109.
22. Lavedan C, Buchholtz S, Auburger G, et al. Absence of mutation in the beta- and gamma-synuclein genes in familial autosomal dominant Parkinson's disease. DNA Res 1998;5:401-402.
23. Bonner LT, Tsuang DW, Cherrier MM, et al. Familial dementia with Lewy bodies with an atypical clinical presentation. J Geriatr Psychiatry Neurol 2003;16:59-64.
24. Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 2001;294:1346-1349.
25. Chung KKK, Dawson VL, Dawson TM. The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders. Trends Neurosci 2001;24(11 suppl):S7-S14.
26. Grody WW, Griffin JH, Taylor AK, Korf BR, Heit JA. American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med 2001;3:139-148.
27. Stratton MR. Recent advances in understanding of genetic susceptibility to breast cancer. Hum Mol Genet 1996;5:1515-1519.
28. Zarranz J, Alegre J, Gomez-Esteban J, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004;55:164-173.
29. Farrer M, Kachergus J, Forno L, et al. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 2004;55:174-179.
30. Singleton AB, Farrer M, Johnson J, et al. Alpha-synuclein locus triplication causes Parkinson's disease. Science 2003;302:841.